TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Urogyn Sverige AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/08 | 2021/08 |
Turnover |
3,495
|
2,904
|
2,460 |
Financial expenses |
42
|
13
|
0 |
Earnings before taxes |
-337
|
3,442
|
4,389 |
EBITDA |
-27,713
|
-13,868
|
-13,333 |
Total assets |
14,332
|
12,445
|
12,532 |
Current assets |
4,333
|
7,328
|
7,605 |
Current liabilities |
4,964
|
1,971
|
2,860 |
Equity capital |
6,178
|
9,497
|
8,589 |
- share capital |
67
|
70
|
73 |
Employees (average) |
23
|
14
|
13 |
Financial ratios
Fiscal year | 2023/12 | 2022/08 | 2021/08 |
Solvency |
43.1%
|
76.3%
|
68.5% |
Turnover per employee |
152
|
207
|
189 |
Profit as a percentage of turnover |
-9.6%
|
118.5%
|
178.4% |
Return on assets (ROA) |
-2.1%
|
27.8%
|
35.0% |
Current ratio |
87.3%
|
371.8%
|
265.9% |
Return on equity (ROE) |
-5.5%
|
36.2%
|
51.1% |
Change turnover |
695
|
563
|
144 |
Change turnover % |
25%
|
24%
|
6% |
Chg. No. of employees |
9
|
1
|
3 |
Chg. No. of employees % |
64%
|
8%
|
30% |
Total value of public sale
Fiscal year | 2023/12 | 2022/08 | 2021/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.